ストックスクリーナーアプリを入手
1.375
2.16%
-0.035
前日終値:
$1.41
開ける：
$1.41
24時間の取引高:
7.93M
Relative Volume:
0.99
時価総額：
$877.74M
収益：
$29.48M
当期純損益:
$-201.19M
株価収益率:
-4.2969
EPS:
-0.32
ネットキャッシュフロー:
$-216.50M
1週間 パフォーマンス:
+5.31%
1か月 パフォーマンス:
+3.73%
6か月 パフォーマンス:
+3.73%
1年 パフォーマンス:
-54.32%
1日の値動き範囲:
$1.35
$1.44
1週間の範囲:
$1.26
$1.44
52週間の値動き範囲:
$1.04
$3.12
Geron Corp Stock (GERN) Company Profile
名前
Geron Corp
セクター
電話
(650) 473-7700
住所
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
GERN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.375 | 900.08M | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.40 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.13 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
815.55 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.91 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.33 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-10 | 再開されました | Goldman | Sell |
| 2025-05-08 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
| 2025-02-27 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-16 | 開始されました | Scotiabank | Sector Outperform |
| 2024-09-09 | 開始されました | Leerink Partners | Outperform |
| 2024-04-30 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | 開始されました | TD Cowen | Buy |
| 2024-03-15 | 繰り返されました | Needham | Buy |
| 2023-09-12 | アップグレード | Goldman | Neutral → Buy |
| 2023-03-28 | 開始されました | Goldman | Neutral |
| 2022-10-28 | 開始されました | Wedbush | Outperform |
| 2022-07-28 | 再開されました | B. Riley Securities | Buy |
| 2021-11-02 | 開始されました | Robert W. Baird | Outperform |
| 2021-02-18 | 再開されました | B. Riley Securities | Buy |
| 2020-08-03 | 開始されました | Stifel | Buy |
| 2019-11-19 | 再開されました | B. Riley FBR | Buy |
| 2019-09-03 | 開始されました | H.C. Wainwright | Buy |
| 2019-08-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-04-09 | アップグレード | Needham | Hold → Buy |
| 2019-01-31 | アップグレード | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | ダウングレード | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | 繰り返されました | FBR & Co. | Outperform |
| 2016-09-13 | 繰り返されました | FBR Capital | Outperform |
| 2015-12-07 | 繰り返されました | Piper Jaffray | Overweight |
| 2015-04-21 | 開始されました | Oppenheimer | Outperform |
| 2014-06-12 | アップグレード | MLV & Co | Hold → Buy |
| 2014-03-12 | ダウングレード | MLV & Co | Buy → Hold |
| 2013-12-10 | 繰り返されました | MLV & Co | Buy |
| 2013-12-10 | アップグレード | Needham | Hold → Buy |
| 2013-11-08 | 繰り返されました | MLV & Co | Buy |
| 2013-10-16 | 開始されました | MLV & Co | Buy |
| 2012-08-30 | 開始されました | Stifel Nicolaus | Buy |
| 2012-06-28 | 開始されました | Needham | Hold |
すべてを表示
Geron Corp (GERN) 最新ニュース
Geron (NASDAQ:GERN) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Geron Corporation (NASDAQ:GERN) Nasdaq Index Clinical-Stage Biotech Profile - Kalkine Media
Geron Corporation (GERN) Eyes Profitability in 2026 amid Restructuring Drive - Insider Monkey
Geron Corporation (GERN) presents new data at the 67th American Society of Hematology 2025 annual meeting - MSN
HC Wainwright Predicts Geron's Q3 Earnings (NASDAQ:GERN) - MarketBeat
Geron Corporation (GERN) Streamlines Operations, Secures Financing, Eyes 2026 Growth - Finviz
What is HC Wainwright's Forecast for Geron FY2030 Earnings? - MarketBeat
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
Geron (NASDAQ:GERN) Stock Price Down 6.6%Here's Why - MarketBeat
Geron forecasts $220-240 million in RYTELO revenue for 2026 - Investing.com
Geron forecasts $220-240 million in RYTELO revenue for 2026 By Investing.com - Investing.com South Africa
Geron (GERN) Forecasts Strong Revenue from RYTELO in 2026 - GuruFocus
Geron (GERN) Outlines Strategic Vision with FY26 Expense Forecas - GuruFocus
Geron shares fall 7.5% premarket after 2026 revenue outlook falls short of estimate - marketscreener.com
Geron Corporation Provides 2026 Financial Guidance - TradingView — Track All Markets
Geron Corporation Provides Earnings Guidance for 2026 - marketscreener.com
Geron Corporation (GERN) Stock Analysis: Exploring a 162.77% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Travel Stocks: What margin trends mean for Geron Corporation stockTrade Performance Summary & Technical Analysis for Trade Confirmation - Bộ Nội Vụ
What valuation multiples suggest for Geron Corporation stockJuly 2025 WrapUp & Reliable Intraday Trade Plans - ulpravda.ru
Will Geron Corporation stock benefit from infrastructure spending2025 Risk Factors & Low Drawdown Investment Ideas - ulpravda.ru
Geron (GERN) Plans Restructuring to Cut Costs, H.C. Wainwright Stays Neutral - Finviz
Geron Corporation Enters into Certain First Amendment to Loan Agreement with Biopharma Credit Investments V LP and BPCR Limited Partnership - marketscreener.com
Geron extends loan agreement deadlines for $250 million credit facility - Investing.com
Geron extends loan agreement deadlines for $250 million credit facility By Investing.com - Investing.com UK
Geron Signs Loan Agreement Amendment With BioPharma Credit - TradingView — Track All Markets
Geron Corporation (NASDAQ:GERN) Given Average Rating of "Hold" by Brokerages - MarketBeat
Geron (NASDAQ:GERN) Shares Cross Above 200 Day Moving AverageTime to Sell? - MarketBeat
Geron Stock Rallies More Than 60% in a Year: Here's Why - MSN
Geron (NASDAQ:GERN) Trading Up 4.9%Time to Buy? - MarketBeat
Geron Corporation (GERN) restructuring to lower operating expenses as it eyes profitability in 2026 - MSN
How Geron Corporation stock compares to market leadersJuly 2025 Price Swings & Precise Buy Zone Identification - Улправда
Can Geron Corporation (GON) stock expand revenue streamsWeekly Trade Report & Smart Investment Allocation Insights - Улправда
What margin trends mean for Geron Corporation stock2025 Volatility Report & Weekly High Potential Alerts - Улправда
Geron: From Launch Hype To Later-Line Gravity (NASDAQ:GERN) - Seeking Alpha
Geron (NASDAQ:GERN) Shares Down 3.9%What's Next? - MarketBeat
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Corporation (GERN) Restructuring to Lower Operating Expenses as it Eyes Profitability in 2026 - Yahoo Finance
Geron (NASDAQ:GERN) Stock Price Up 5.6%Here's What Happened - MarketBeat
14 Best Multibagger Penny Stocks to Buy Right Now - Insider Monkey
Geron Corporation (NASDAQ: GERN) plans workforce cuts, expects $18M charges - Stock Titan
Squarepoint Ops LLC Increases Stock Position in Geron Corporation $GERN - MarketBeat
Bay Area biotech company, down $1.7 billion in value, lays off a third of staff - SFGATE
Geron (NASDAQ:GERN) Trading Up 8.2%What's Next? - MarketBeat
Geron Stock (NASDAQ: GERN) News Today: Restructuring, Analyst Ratings, and 2026 Catalysts (Dec. 12, 2025) - ts2.tech
Geron stock falls as H.C. Wainwright reiterates Neutral rating amid restructuring - Investing.com
Praxis tees up another approval filing; Geron turns to layoffs - Yahoo Finance
Geron Corporation (NASDAQ:GERN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Geron Corporation (GERN) Presents New Data at the 67th American Society of Hematology 2025 Annual Meeting - Finviz
Foster City drug maker Geron to lay off one-third of staff under new CEOSan Francisco Business Times - The Business Journals
Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On Sidelines (GERN) - Seeking Alpha
Geron Corporation (GERN) Announces Significant Workforce Reducti - GuruFocus
Geron Corp (GERN) 財務データ
収益
当期純利益
現金流量
EPS
3.31%
2.06%
大文字化:
|
ボリューム (24 時間):